Search

This study presents an application of machine learning (ML) methods for detecting the presence of stenoses and aneurysms in the human arterial system. Four major forms of arterial disease -- carotid artery stenosis (CAS), subclavian artery stenosis (SAC), peripheral arterial disease (PAD), and abdominal aortic aneurysms (AAA) -- are considered. The ML methods are trained and tested on a physiologically realistic virtual patient database (VPD) containing 28,868 healthy subjects, which is adapted from the authors previous work and augmented to include the four disease forms. Six ML methods -- Naive Bayes, Logistic Regression, Support Vector Machine, Multi-layer Perceptron, Random Forests, and Gradient Boosting -- are compared with respect to classification accuracies and it is found that the tree-based methods of Random Forest and Gradient Boosting outperform other approaches. The performance of ML methods is quantified through the F1 score and computation of sensitivities and specificities. When using all the six measurements, it is found that maximum F1 scores larger than 0.9 are achieved for CAS and PAD, larger than 0.85 for SAS, and larger than 0.98 for both low- and high-severity AAAs. Corresponding sensitivities and specificities are larger than 90% for CAS and PAD, larger than 85% for SAS, and larger than 98% for both low- and high-severity AAAs. When reducing the number of measurements, it is found that the performance is degraded by less than 5% when three measurements are used, and less than 10% when only two measurements are used for classification. For AAA, it is shown that F1 scores larger than 0.85 and corresponding sensitivities and specificities larger than 85% are achievable when using only a single measurement. The results are encouraging to pursue AAA monitoring and screening through wearable devices which can reliably measure pressure or flow-rates, Changelog: Added a bullet point in the discussion (end of section 3.3)

This proof of concept (PoC) assesses the ability of machine learning (ML) classifiers to predict the presence of a stenosis in a three vessel arterial system consisting of the abdominal aorta bifurcating into the two common iliacs. A virtual patient database (VPD) is created using one-dimensional pulse wave propagation model of haemodynamics. Four different machine learning (ML) methods are used to train and test a series of classifiers-both binary and multiclass-to distinguish between healthy and unhealthy virtual patients (VPs) using different combinations of pressure and flow-rate measurements. It is found that the ML classifiers achieve specificities larger than 80% and sensitivities ranging from 50 to 75%. The most balanced classifier also achieves an area under the receiver operative characteristic curve of 0.75, outperforming approximately 20 methods used in clinical practice, and thus placing the method as moderately accurate. Other important observations from this study are that (i) few measurements can provide similar classification accuracies compared to the case when more/all the measurements are used; (ii) some measurements are more informative than others for classification; and (iii) a modification of standard methods can result in detection of not only the presence of stenosis, but also the stenosed vessel. Graphical Abstract An overview of methodology fo the creation of virtual patients and their classification.

BACKGROUND Objective symptom monitoring of patients with Amyotrophic Lateral Sclerosis (ALS) has the potential to provide an important source of information to evaluate the impact of the disease on aspects of real-world functional capacity and activities of daily living in the home setting, providing useful objective outcome measures for clinical trials. OBJECTIVE This study aimed to investigate the feasibility of a novel digital platform for remote data collection of multiple symptoms—physical activity, heart rate variability (HRV), and digital speech characteristics—in 25 patients with ALS in an observational clinical trial setting to explore the impact of the devices on patients’ everyday life and to record tolerability related to the devices and study procedures over 48 weeks. METHODS In this exploratory, noncontrolled, nondrug study, patients attended a clinical site visit every 3 months to perform activity reference tasks while wearing a sensor, to conduct digital speech tests and for conventional ALS monitoring. In addition, patients wore the sensor in their daily life for approximately 3 days every month for the duration of the study. RESULTS The amount and quality of digital speech data captured at the clinical sites were as intended, and there were no significant issues. All the home monitoring sensor data available were propagated through the system and were received as expected. However, the amount and quality of physical activity home monitoring data were lower than anticipated. A total of 3 or more days (or partial days) of data were recorded for 65% of protocol time points, with no data collected for 24% of time points. At baseline, 24 of 25 patients provided data, reduced to 13 of 18 patients at Week 48. Lower-than-expected quality HRV data were obtained, likely because of poor contact between the sensor and the skin. In total, 6 of 25 patients had mild or moderate adverse events (AEs) in the skin and subcutaneous tissue disorders category because of skin irritation caused by the electrode patch. There were no reports of serious AEs or deaths. Most patients found the sensor comfortable, with no or minimal impact on daily activities. CONCLUSIONS The platform can measure physical activity in patients with ALS in their home environment; patients used the equipment successfully, and it was generally well tolerated. The quantity of home monitoring physical activity data was lower than expected, although it was sufficient to allow investigation of novel physical activity end points. Good-quality in-clinic speech data were successfully captured for analysis. Future studies using objective patient monitoring approaches, combined with the most current technological advances, may be useful to elucidate novel digital biomarkers of disease progression.

Les musees consacres aux sciences et aux techniques sont aujourd'hui tres apprecies du public et surtout, semble-t-il, des jeunes. Dans cet article, le Directeur general du Centre des sciences de l'Ontario (Canada) se livre a une analyse sans fard de quelques-uns des principaux problemes que rencontre ce type de musees.

This study assessed the potential for using dietary phytase to improve the nutritive value of canola protein concentrate (CPC) for rainbow trout, and to concomitantly minimize phosphorus discharge into the environment. Eight diets were prepared. LT-anchovy meal (AM) provided 89% of the protein in the basal diet, whereas in the remaining diets, 59% of the protein originated from CPC by replacement of AM protein. Four CPC diets were supplemented with phytase (Natuphos®) at levels of either 0, 500, 1500 or 4500 phytase units (FTU)/kg diet together with 4505 mg/kg phosphorus. Two CPC diets contained 1500 FTU/kg and either 0 or 2253 mg/kg of supplemental phosphorus. The seventh CPC diet contained no phytase or supplemental phosphorus. A commercial trout feed served as an industry control. All diets were fed to triplicate groups of rainbow trout (initial weight, 17.9 g) to satiation daily for 84 days. Mean water temperature was 11.0°C. The level of phytic acid degradation and the apparent availability of dietary phosphorus were ascertained for all groups. Fish fed the CPC diets, regardless of their phytase and phosphorus levels, exhibited growth rates, feed efficiencies and protein utilization comparable to those of control fish. There was, however, a clear positive dose-response of phytase on dietary phytate digestibility and phosphorus availability was improved significantly by the highest level of phytase. We conclude that dietary phytase has potential to improve the nutritive quality of CPC for rainbow trout and the availability of phytate phosphorus.